Study explains loss of efficacy of common type 2 diabetes drug
Post Details (Top)
Desktop Banner (This ad will be displayed on screens larger than 992px)
Mobile Banner (This ad will be displayed on screens smaller than 992px)
Type 2 diabetes medications, such as sulfonylureas, have been a mainstay of treating the disease since they came on the market in the early 1950s. However, although they are one of the most common drugs for this condition, it is not surprising that they lose effectiveness over time and have been seen to often cause more side effects than other antidiabetic drugs.
In-Article-1
Desktop Banner (This ad will be displayed on screens larger than 992px)
Mobile Banner (This ad will be displayed on screens smaller than 992px)
In-Article-2 Desktop Banner (This ad will be displayed on screens larger than 992p
Mobile Banner (This ad will be displayed on screens smaller than 992px)
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Carver
Carver who carves the news
Post Details (Bottom)
Desktop Banner (This ad will be displayed on screens larger than 992px)
Mobile Banner (This ad will be displayed on screens smaller than 992px)
